Results 161 to 170 of about 77,535 (306)

Four secondary malignancies, coronary artery disease, aortic atherosclerosis and severe constrictive pericarditis in a survivor of hodgkin lymphoma treated with radiation therapy: a case report

, 2023
Antoine Jeri-Yabar, J. Garazatua-Gonzalez, Wency Cecilia Montoya-Rivera, Victor Ortuzar-Seminario, C. Lozada Zingoni, V. Massuco   +5 more
openalex   +2 more sources

Validation of prognostic scores in patients with HIV‐related diffuse large B‐cell lymphoma: The value of peripheral blood parameters—A study from the Spanish Lymphoma Group GELTAMO

British Journal of Haematology, EarlyView.
Maria Huguet, Mireia Morgades, Alfredo Rivas‐Delgado, Mariana Bastos‐Oreiro, Raúl Córdoba, Antonio Salar, Fátima de la Cruz‐Vicente, Miguel Alcoceba, Blanca Ferrer‐Lores, Ana Jiménez‐Ubieto, Antonio Gutiérrez, María Infante, Sofía Huerga, Pau Abrisqueta, David Cruz, Carlos Montalbán, Ana Muntañola, Sonia González‐de Villambrosia, Josep‐Maria Ribera, José‐Tomás Navarro   +19 more
wiley   +1 more source

Emerging Techniques in Minimally Invasive Surgery in Hematologic Malignancies

European Journal of Haematology, EarlyView.
ABSTRACT Hematologic malignancies represent the most common cancers in children. While the mainstays of treatment are chemotherapy and potentially hematopoietic stem cell transplant, minimally invasive surgery (MIS) has a role in the diagnosis and management of complications related both to disease and therapy as well as common pediatric surgical ...
Alejandro Chara, Katlyn G. McKay, Harold N. Lovvorn III, Joseph C. Fusco   +3 more
wiley   +1 more source

Classical Hodgkin lymphoma associated with immune deficiency and dysregulation exhibits a prognosis similar to sporadic cases but with distinct predictive markers. [PDF]

Ann Hematol
Mukae J, Akiyama H, Tanaka K, Yoshifuji K, Nogami A, Umezawa N, Umezawa Y, Yamamoto K, Nagao T, Yasuda S, Kanegane H, Takagi M, Mori T, Yamamoto M.   +13 more
europepmc   +1 more source

Asymptomatic chest wall Hodgkin disease mimicking fibrosing mediastinitis [PDF]

, 2006
Charalambos Zisis, Emmanuel Kefaloyannis, Dimitra Rontogianni, Fani Michalopoulou, Ioannis Kalomenidis, Spyros A. Papiris, Ion Bellenis   +6 more
openalex   +1 more source

Factors Affecting Immune Reconstitution Post‐Allogeneic HSCT in Children: The Case for an Individualized Approach to Vaccination

European Journal of Haematology, EarlyView.
ABSTRACT Allogeneic hematopoietic stem cell transplantation (HSCT) is increasingly used to treat malignant and non‐malignant diseases. Following allogeneic HSCT, patients are particularly vulnerable to vaccine‐preventable diseases (VPD) because conditioning depletes immune cells, including memory cells.
Hélène Buvelot, Frederic Baleydier, Laure Pittet, Geraldine Blanchard‐Rohner   +3 more
wiley   +1 more source

Pharma steps back from Hodgkin lymphoma: now what? [PDF]

Blood Adv
Lynch RC, Gopal AK.
europepmc   +1 more source

Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets

, 2017
Elena Mata, Antonio Díaz‐López, Ana M. Martín‐Moreno, Margarita Sánchez‐Beato, Ignacio Varela, María J. Mestre, Carlos Santonja, Fernando Burgos, Javier Menárguez, Mónica Estévez, Mariano Provencio, Beatriz Sánchez‐Espiridión, Eva Díaz, Carlos Montalbán, Miguel Á. Piris, Juan F. Garcı́a   +15 more
openalex   +2 more sources

The role of FDG‐PET/CT in the evaluation of residual disease in paediatric non‐Hodgkin lymphoma [PDF]

, 2014
Deepa Bhojwani, M. Beth McCarville, John Choi, Jennifer Sawyer, Monika L. Metzger, Hiroto Inaba, Andrew M. Davidoff, R. E. Gold, Barry L. Shulkin, John T. Sandlund   +9 more
openalex   +1 more source

Beyond PD‐1: Mechanisms of Resistance to Checkpoint Blockade in Classical Hodgkin Lymphoma and Next‐Generation Immune Strategies

European Journal of Haematology, EarlyView.
ABSTRACT PD‐1 inhibitors have reshaped the treatment landscape of classical Hodgkin lymphoma, yet a substantial proportion of patients exhibit primary or acquired resistance driven by tumor‐intrinsic alterations, immunosuppressive microenvironmental signals, metabolic constraints, and EBV‐mediated modulation.
Santino Caserta, Enrica Antonia Martino, Mamdouh Skafi, Maria Eugenia Alvaro, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Ernesto Vigna, Fortunato Morabito, Massimo Gentile   +12 more
wiley   +1 more source